Birhan Demirhan

Iskenderun, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Stereotactic body radiotherapy for bone-only oligometastatic bladder Cancer: a multi-institutional experience.

Stereotactic body radiotherapy for bone-only oligometastatic bladder Cancer: a multi-institutional experience.

Journal: Clinical and translational radiation oncology

Published: June 15, 2026

Development of a Novel Nomogram to Predict Biochemical Failure and Prostate Cancer-Specific Mortality After Definitive Radiotherapy in Patients with Gleason Score 7 Prostate Cancer.

Development of a Novel Nomogram to Predict Biochemical Failure and Prostate Cancer-Specific Mortality After Definitive Radiotherapy in Patients with Gleason Score 7 Prostate Cancer.

Journal: Archivos espanoles de urologia

Published: May 09, 2026

A comparison of dimensionality reduction approaches for pre-treatment PSMA-PET/CT radiomics in prostate adenocarcinoma outcome prediction.

A comparison of dimensionality reduction approaches for pre-treatment PSMA-PET/CT radiomics in prostate adenocarcinoma outcome prediction.

Journal: Radiation medicine and protection

Published: March 19, 2026

Post-treatment diffusion MRI-derived apparent diffusion coefficient as a biomarker of response and prognosis following definitive radiotherapy for prostate cancer: Impact of focal dose escalation on ADC dynamics.

Post-treatment diffusion MRI-derived apparent diffusion coefficient as a biomarker of response and prognosis following definitive radiotherapy for prostate cancer: Impact of focal dose escalation on ADC dynamics.

Journal: Urologic oncology

Published: February 18, 2026

Prediction of Metastasis-Free Survival in Patients with Localized Prostate Adenocarcinoma Using Delta Radiomics from Pre-Treatment PSMA-PET/CT Scans and Dosiomics.

Prediction of Metastasis-Free Survival in Patients with Localized Prostate Adenocarcinoma Using Delta Radiomics from Pre-Treatment PSMA-PET/CT Scans and Dosiomics.

Journal: Cancers

Published: January 08, 2026

Impact of Intraprostatic Simultaneous Integrated Boost on Long-Term Outcomes in Unfavorable Intermediate-Risk Prostate Cancer Treated With Dose-Escalated Radiotherapy and Short-Term Androgen Deprivation Therapy.

Impact of Intraprostatic Simultaneous Integrated Boost on Long-Term Outcomes in Unfavorable Intermediate-Risk Prostate Cancer Treated With Dose-Escalated Radiotherapy and Short-Term Androgen Deprivation Therapy.

Journal: The Prostate

Published: January 04, 2026

Response letter to the Commentary "Peri-Tumoral ring Radiomics: Vein-Contaminated Voxels Inflate MFS Scores".

Response letter to the Commentary "Peri-Tumoral ring Radiomics: Vein-Contaminated Voxels Inflate MFS Scores".

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: October 20, 2025

Does transurethral resection of prostate increase toxicity risk after simultaneous integrated boost radiotherapy? A matched cohort study with long-term follow-up.

Does transurethral resection of prostate increase toxicity risk after simultaneous integrated boost radiotherapy? A matched cohort study with long-term follow-up.

Journal: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]

Published: July 05, 2025

Long term outcomes of prostate cancer patients aged 55 years or younger treated with definitive radiotherapy: Trod 09-005 study.

Long term outcomes of prostate cancer patients aged 55 years or younger treated with definitive radiotherapy: Trod 09-005 study.

Journal: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]

Published: June 02, 2025

Re: Daniela E. Oprea-Lagera, Tessa van Elst, Shafak Aluwini, et al. How Does Routine Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Modify the Current Management of Prostate Cancer? A Multidisciplinary View. Eur Urol Open Sci 2025; 75: 69-79.

Re: Daniela E. Oprea-Lagera, Tessa van Elst, Shafak Aluwini, et al. How Does Routine Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Modify the Current Management of Prostate Cancer? A Multidisciplinary View. Eur Urol Open Sci 2025; 75: 69-79.

Journal: European urology open science

Published: May 30, 2025

Dose Accumulation for Pelvic Stereotactic Ablative Body Radiotherapy Reirradiation. In Regard to Slevin et al.

Dose Accumulation for Pelvic Stereotactic Ablative Body Radiotherapy Reirradiation. In Regard to Slevin et al.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: May 21, 2025

SBRT Boost in Prostate Cancer: Progress Made, Questions Remain.

SBRT Boost in Prostate Cancer: Progress Made, Questions Remain.

Journal: The Prostate

Published: May 12, 2025

Showing 1-12 of 31

Last Updated: 09/26/2026